Tag: late-on-monday
-
J&J says pharma future bright, despite threat to Remicade
Pfizer Inc late on Monday said it would begin U.S. shipments of Inflectra, its biosimilar form of Remicade, by late November at a 15 percent discount to J&J's current wholesale prices. With annual U.S. sales of about $5 billion, Remicade is J&J's biggest product. “We are confident our pharma business will go well with or…
-
China toughens drug quality standards, rejects 13 applications
(Reuters) – China's food and drug regulator said late on Monday it had rejected applications for 13 new drugs, citing false or incomplete trial data, as the government toughens enforcement of quality standards. The regulator's crackdown comes after it called on manufacturers to carry out their own internal investigations into trial data in July, a…